🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Tick-borne Encephalitis (TBE) can be prevented by vaccine. Vaccine failure,...
Status
Unknown
Location
Region Örebro Län
Start Date
2024-01
Trial ID
NCT04573205
Treatments Being Tested
This study will evaluate the durability of antibody responses in children a...
Status
Completed
Location
Winkelhoferstr. 3
Start Date
2009-05
Trial ID
NCT01106482
Treatments Being Tested
The risk for tick borne encephalitis increases in Sweden. Together with an ...
Status
Completed
Location
Dept infectious diseases
Start Date
2015-01
Trial ID
NCT02318069
Treatments Being Tested
The purpose of this study is to investigate the safety and immunogenicity o...
Status
Completed
Location
Neuschwanstein Strasse 5
Start Date
2002-02
Trial ID
NCT00161889
Treatments Being Tested
The purpose of this study is to investigate the safety and immunogenicity o...
Status
Completed
Location
Grieskirchner Strasse 17
Start Date
2002-02
Trial ID
NCT00161850
Treatments Being Tested
The goal of this observational study is to learn about vaccine immunity in ...
Status
Recruiting
Location
University Hospital Bern
Start Date
2023-11-14
Trial ID
NCT06333275
The purpose of this study is to assess the seropersistence of TBE antibodie...
Status
Completed
Location
Grieskirchner Strasse 17
Start Date
2005-05
Trial ID
NCT00161967
Treatments Being Tested
The purpose of this study it is to evalutate the persistence of antibodies ...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00311493
Treatments Being Tested
The aim of this study is to evaluate the safety of the third vaccination wi...
Status
Completed
Location
Zespol Opieki Zdrowotnej w Debicy
Start Date
2002-05
Trial ID
NCT00161876
Treatments Being Tested
The purpose of this study is to investigate the safety and immunogenicity o...
Status
Completed
Location
Grieskirchner Strasse 17
Start Date
2002-03
Trial ID
NCT00161772
Treatments Being Tested